Cambodia Pharmaceutical Market: Size, Growth, Opportunities (2024)

Market Overview

• Size (2023): ~US$400–450 million (retail + hospital).
• Growth: 10–12% CAGR (2023–2028). Driven by rising incomes, health awareness, insurance expansion (NSSF), urbanization.
• Per Capita Spend: ~$25 (low vs. Thailand $100+, Vietnam $60). High upside.

Segments

• Prescription (Rx): ~60%. NCDs rising (CVD, diabetes, cancer). Antibiotics, cardiovasculars, antidiabetics lead.
• OTC: ~25%. Analgesics, cough/cold, vitamins, dermatologics. Growing self-medication.
• Traditional/Herbal: ~15%. Kru Khmer medicine, Chinese herbs, supplements. Coexists with modern pharma.

Market Structure

• Imports: 85–90% (India, China, Europe, Thailand, Vietnam). India = generics leader.
• Local Manufacturing: ~10 licensed factories (e.g., Pharma Product Manufacturing, Atlantic). Fill/finish, some API. GMP upgrading.
• Distribution: Wholesalers → pharmacies (5,000+), hospitals, clinics. Fragmented. Modern chains (Ucare, Sunny) expanding.
• Regulation: Department of Drugs & Food (DDF), MOH. ASEAN harmonization ongoing. Registration 12–24 months.

Opportunities & Barriers

Opportunities: NCD portfolio, vaccines, biosimilars, OTC switch, contract manufacturing, digital pharmacy.

Barriers: Price controls (reference pricing), IP enforcement weak, counterfeit prevalence (~10%), skills shortage, informal payments.